Cited by 2,833Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Open access

Cohn, Jay N., Johnson, Gary, Ziesche, Susan, Cobb, Frederick, Francis, Gary, Tristani, Felix, Smith, Raphael, Dunkman, W. Bruce, Loeb, Henry, Wong, Maylene, Bhat, Geetha, Goldman, Steven, Fletcher, Ross D., Doherty, James, Hughes, C. Vincent, Carson, Peter, Cintron, Guillermo, Shabetai, Ralph, Haakenson, Clair·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250502

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: To define better the efficacy of vasodilator therapy in the treatment of chronic congestive heart failure, we compared the effects of hydralazine and isosorbide dinitrate with those of enalapril in 804 men receiving digoxin and diuretic therapy for heart failure. The patients were randomly assigned in a double-blind manner to receive 20 mg of enalapril daily or 300 mg of hydralazine plus 160 mg of isosorbide dinitrate daily. The latter regimen was identical to that used with a similar patient population in the effective-treatment arm of our previous Vasodilator-Heart Failure Trial. RESULTS: Mortality after two years was significantly lower in the enalapril arm (18 percent) than in the hydralazine-isosorbide dinitrate arm (25 percent) (P = 0.016; reduction in mortality, 28.0 percent), and overall mortality tended to be lower (P = 0.08). The lower mortality in the enalapril arm was attributable to a reduction in the incidence of sudden death, and this beneficial effect was more prominent in patients with less severe symptoms (New York Heart Association class I or II). In contrast, body oxygen consumption at peak exercise was increased only by hydralazine-isosorbide dinitrate treatment (P less than 0.05), and left ventricular ejection fraction, which increased with both regimens during the 2 years after randomization, increased more (P less than 0.05) during the first 13 weeks in the hydralazine-isosorbide dinitrate group. CONCLUSIONS: The similar two-year mortality in the hydralazine-isosorbide dinitrate arms in our previous Vasodilator-Heart Failure Trial (26 percent) and in the present trial (25 percent), as compared with that in the placebo arm in the previous trial, (34 percent) and the further survival benefit with enalapril in the present trial (18 percent) strengthen the conclusion that vasodilator therapy should be included in the standard treatment for heart failure. The different effects of the two regimens (enalapril and hydralazine-isosorbide dinitrate) on mortality and physiologic end points suggest that the profile of effects might be enhanced if the regimens were used in combination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250502

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Self-citation
A placebo-controlled trial of captopril in refractory chronic congestive heart failure
Captopril Multicenter Research Group (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80316-7 · Cited by 588
Vasodilator Therapy of Cardiac Failure
Cohn, J. N., & Franciosa, J. A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707072970105 · Cited by 483
Self-citation
The role of vasodilator therapy in heart failure
Chatterjee, K., & Parmley, W. W. (1977) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(77)90006-8 · Cited by 315
Vasodilator Therapy for Heart Failure
Cohn, J. N. (1973) · Circulation · doi:10.1161/01.cir.48.1.5 · Cited by 293
Self-citation
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
Leier, C. V., Huss, P., Magorien, R. D., & Unverferth, D. V. (1983) · Circulation · doi:10.1161/01.cir.67.4.817 · Cited by 289

Show all 19 references

Research works printed but not linked: 1

Cohn, 1987, Circulation, 76, IV–443

Sorted by citations

Items 401–500 of 1,000

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
Houghton, A. R., & Cowley, A. J. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02904-x · Cited by 95
The Prevention of Heart Failure — A New Agenda
Cohn, J. N. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271010 · Cited by 95
Self-citation
Left Ventricular Performance and Remodeling in Rabbits After Myocardial Infarction: Effects of a Thyroid Hormone Analogue
Mahaffey, K. W., Raya, T. E., Pennock, G. D., Morkin, E., & Goldman, S. (1995) · Circulation · doi:10.1161/01.cir.91.3.794 · Cited by 94
Self-citation
Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging
Chen, J., Henneman, M. M., Trimble, M. A., Bax, J. J., Borges‐Neto, S., Iskandrian, A. E., Nichols, K. J., & Garcia, E. V. (2008) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2007.11.004 · Cited by 95
Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the studies of left ventricular dysfunction (SOLVD) treatment trial
Glick, H. A., Cook, J. R., Kinosian, B. P., Pitt, B., Bourassa, M. G., Pouleur, H. G., & Gerth, W. C. (1995) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(05)80006-5 · Cited by 94
The clinical use of angiotensin-converting enzyme inhibitors
Wong, J. S., Patel, R. A., & Kowey, P. R. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.04.003 · Cited by 95
Peripartum cardiomyopathy
Murali, S., & Baldisseri, M. R. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000183500.47273.8e · Cited by 93
Adverse Effects of the Angiotensin-Converting Enzyme Inhibitors
Alderman, C. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000110 · Cited by 93
Congestive heart failure in pediatric patients
Kay, J. D., Colan, S. D., & Graham, T. P. (2001) · American Heart Journal · doi:10.1067/mhj.2001.119423 · Cited by 93
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
Narang, R., Swedberg, K. B., & Cleland, J. G. F. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014670 · Cited by 92
Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: A double-blind, placebo-controlled study of quinapril
Pflugfelder, P. W., Baird, G., Tonkon, M. J., DiBianco, R., & Pitt, B. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90578-o · Cited by 91
Airway Compromise Due to Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
Sondhi, D., Lippmann, M. L., & Murali, G. (2004) · CHEST Journal · doi:10.1378/chest.126.2.400 · Cited by 91
Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes
Dodge, S. M., Beardslee, M. A., Darrow, B. J., Green, K. G., Beyer, E. C., & Saffitz, J. E. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00317-9 · Cited by 91
Change in Comorbidity Prevalence with Advancing Age Among Persons with Heart Failure
Ahluwalia, S. C., Gross, C. P., Chaudhry, S. I., Leo-Summers, L. S., Ness, P. H. V., & Fried, T. R. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1725-6 · Cited by 90
Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial
Staszewsky, L. I., Wong, M., Masson, S., Barlera, S., Carretta, E., Maggioni, A. P., Anand, I. S., Cohn, J. N., Tognoni, G., & Latini, R. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.07.012 · Cited by 91
Self-citation
Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges
Khand, A. U. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2175 · Cited by 90
Global gene expression in human myocardium?oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure
Kääb, S., Barth, A. S., Margerie, D., Dugas, M., Gebauer, M., Zwermann, L., Merk, S., Pfeufer, A., Steinmeyer, K., Bleich, M., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0527-2 · Cited by 90
Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure.
Litwin, S. E., & Morgan, J. P. (1992) · Circulation Research · doi:10.1161/01.res.71.4.797 · Cited by 90
Effect of amlodipine on mode of death among patients with advanced heart failure in the praise trial
O’Connor, C. M., Carson, P. E., Miller, A. B., Pressler, M. L., Belkin, R. N., Neuberg, G. W., Frid, D. J., Cropp, A. B., Anderson, S., WERTHEIMER, J. H., et al. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00496-2 · Cited by 89
Self-citation
Digitalis Therapy for Patients in Clinical Heart Failure
Rahimtoola, S. H. (2004) · Circulation · doi:10.1161/01.cir.0000132477.32438.03 · Cited by 89
Myocarditis and idiopathic dilated cardiomyopathy
Brown, C., & OʼConnell, J. B. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80164-8 · Cited by 89
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials
Tai, C., Gan, T., Zou, L., Sun, Y., Zhang, Y., Chen, W., Li, J., Zhang, J., Xu, Y., Lu, H.-H., et al. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0686-z · Cited by 88
Acute and Chronic Effects of Propionyl-L-Carnitine on the Hemodynamics, Exercise Capacity, and Hormones in Patients with Congestive Heart Failure
Anand, I. S., Chandrashekhan, Y., Giuli, F. D., Pasini, E., Mazzoletti, A., Confortini, R., & Ferrari, R. (1998) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007721917561 · Cited by 88
ACE Inhibitors in Pediatric Patients with Heart Failure
Momma, K. (2006) · Pediatric Drugs · doi:10.2165/00148581-200608010-00005 · Cited by 88
Comparison of Medical Therapy Dosing in Outpatients Cared for in Cardiology Practices With Heart Failure and Reduced Ejection Fraction With and Without Device Therapy
Heywood, J. T., Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Gheorghiade, M., Inge, P. J., McBride, M. L., Mehra, M. R., O’Connor, C. M., et al. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.912683 · Cited by 88
Stress-Induced Left Ventricular Outflow Tract Obstruction: A Potential Cause of Dyspnea in the Elderly
Henein, M., O’Sullivan, C. A., Sutton, G. C., Gibson, D. G., & Coats, A. J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00303-3 · Cited by 88
Oral Torsemide in Patients With Chronic Congestive Heart Failure: Effects on Body Weight, Edema, and Electrolyte Excretion
Patterson, J. H., Adams, K. F., Applefeld, M. M., Corder, C. N., Mâsse, B. R., & The Torsemide Investigators Group (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02848.x · Cited by 88
Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function
Philbin, E. F., & Rocco, T. A. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70123-6 · Cited by 88
Hydralazine and Isosorbide Dinitrate in Heart Failure
Cole, R. T., Kalogeropoulos, A. P., Georgiopoulou, V. V., Gheorghiade, M., Quyyumi, A. A., Yancy, C. W., & Butler, J. (2011) · Circulation · doi:10.1161/circulationaha.110.012781 · Cited by 88
Discordance in degree of right and left ventricular dilation in patients with dilated cardiomyopathy: Recognition and clinical implications
Lewis, J. F., Webber, J. D., Sutton, L. L., Chesoni, S., & Curry, C. L. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90097-k · Cited by 86
HIGH TUMOUR NECROSIS FACTOR-α LEVELS ARE ASSOCIATED WITH EXERCISE INTOLERANCE AND NEUROHORMONAL ACTIVATION IN CHRONIC HEART FAILURE PATIENTS
Cicoira, M., Bolger, A. P., Doehner, W., Rauchhaus, M., Davos, C. H., Sharma, R. K., Al-Nasser, F., Coats, A. J. S., & Anker, S. D. (2001) · Cytokine · doi:10.1006/cyto.2001.0918 · Cited by 85
Modulation of Cardiac Autonomic Control in Humans by Angiotensin II
Townend, J., Al-Ani, M., West, J. N. W., Littler, W. A., & Coote, J. H. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1270 · Cited by 85
Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure
Lopatin, Y. M., Rosano, G. M. C., Fragasso, G., Lopaschuk, G. D., Seferovic, P. M., Gowdak, L. H. W., Vinereanu, D., Abdelhamid, M., Patrick Jourdain, M., & Ponikowski, P. P. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.11.060 · Cited by 84
Cardiopulmonary Exercise Testing
Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Circulation · doi:10.1161/01.cir.0000136811.45524.2f · Cited by 85
Cost-effectiveness of heart failure therapies
Rohde, L. E. P., Bertoldi, E. G., Goldraich, L. A., & Polanczyk, C. A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.60 · Cited by 86
State of the art paper Heart failure in the diabetic population – pathophysiology, diagnosis and management
Kasznicki, J., & Drzewoski, J. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.43748 · Cited by 83
Interactions between the sympathetic nervous system and the RAAS in heart failure
Goldsmith, S. R. (2004) · Current Heart Failure Reports · doi:10.1007/s11897-004-0024-5 · Cited by 84
Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
Toyama, T., Aihara, Y., Iwasaki, T., Hasegawa, A., Suzuki, T., Nagai, R., Endo, K., Hoshizaki, H., Oshima, S., & Taniguchi, K. (1999) · PubMed · Cited by 83
Toleration of High Doses of Angiotensin-Converting Enzyme Inhibitors in Patients With Chronic Heart Failure
Massie, B. M., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Packer, M., Poole-Wilson, P. A., & Rydén, L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.165 · Cited by 83
AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions
Willenheimer, R. B. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1547 · Cited by 83
Heart failure in women
Lund, L. H., & MANCINI, D. M. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.03.003 · Cited by 84
Endothelial Nitric Oxide Synthase (NOS3) Polymorphisms in African Americans With Heart Failure: Results From the A-HeFT Trial
McNamara, D. M., Tam, S. W., Sabolinski, M. L., Tobelmann, P., Janosko, K. M., Venkitachalam, L., Ofili, E., Yancy, C. W., Feldman, A. M., Ghali, J. K., et al. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.10.028 · Cited by 83
Self-citation
Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure
Thadani, U. (1997) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00053031 · Cited by 82
Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial
Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Moum, T., Abdelnoor, M., EGELAND, T., Endresen, K., Ilebekk, A., Mangschau, A., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.003 · Cited by 82
Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment
Alderman, M. H., Cohen, H. W., & Madhavan, S. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816060-00007 · Cited by 82
Treatment of chronic heart failure
Packer, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90406-s · Cited by 82
Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
Packer, M. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00301-4 · Cited by 82
Towards precision medicine in heart failure
Weldy, C. S., & Ashley, E. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00566-9 · Cited by 81
Effect of Increasing Pump Speed During Exercise on Peak Oxygen Uptake in Heart Failure Patients Supported with a Continuous-Flow Left Ventricular Assist Device. A Double-Blind Randomized Study
Jung, M. H., Hansen, P. B., Sander, K., Olsen, P. S., Rossing, K., Boesgaard, S., Russell, S. D., & Gustafsson, F. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.52 · Cited by 81
Peripartum Cardiomyopathy: Review of the Literature
Bhakta, P., Biswas, B. K., & Banerjee, B. (2007) · Yonsei Medical Journal · doi:10.3349/ymj.2007.48.5.731 · Cited by 81
Side effects of using nitrates to treat angina
Thadani, U., & Rodgers, T. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.5.667 · Cited by 82
Ventricular arrhythmia in congestive heart failure
Podrid, P. J., Fogel, R. I., & Fuchs, T. T. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91257-5 · Cited by 81
Effect of the Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene on Response to Angiotensin-Converting Enzyme Inhibitors in Patients with Heart Failure
O’Toole, L., Stewart, M., Padfield, P. L., & Channer, K. S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199812000-00017 · Cited by 82
Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): Baseline characteristics, prognosis and response to therapy in the vasodilator in heart failure trials (V-HeFT)
Carson, P. E., Johnson, G. R., Fletcher, R. D., & Cohn, J. N. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00503-x · Cited by 81
Self-citation
Medication Dosing in Outpatients With Heart Failure After Implementation of a Practice‐Based Performance Improvement Intervention: Findings From IMPROVE HF
Gheorghiade, M., Albert, N. M., Curtis, A. B., Heywood, J. T., McBride, M. L., Inge, P. J., Mehra, M. R., O’Connor, C. M., REYNOLDS, D. W., Walsh, M. N., et al. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00250.x · Cited by 80
Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure
Cleland, J. G. F., Chattopadhyay, S., Khand, A. U., Houghton, T., & Kaye, G. (2002) · Heart Failure Reviews · doi:10.1023/a:1020024122726 · Cited by 81
Factors determining angiotensin‐converting enzyme inhibitor underutilization in heart failure in a community setting
Philbin, E. F. (1998) · Clinical Cardiology · doi:10.1002/clc.4960210208 · Cited by 80
Heart failure in African Americans: Disparities can be overcome
Sharma, A. K., Colvin, M. M., & Yancy, C. W. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.81a.13045 · Cited by 87
Management of acute decompensated heart failure
Allen, L. A., & O'Connor, C. M. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.051620 · Cited by 80
Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2
Barron, H. V., Michaels, A. D., Maynard, C. C., & Every, N. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00225-3 · Cited by 79
The Clinical Potential of Endothelin Receptor Antagonists in Cardiovascular Medicine
Ferro, C. J., & Webb, D. J. (1996) · Drugs · doi:10.2165/00003495-199651010-00003 · Cited by 79
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges
Zannad, F. M., Stough, W. G., Regnault, V., Gheorghiade, M., Deliargyris, E., Gibson, C. M., Agewall, S., Berkowitz, S. D., Burton, P. B. J., Calvo, G., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.018 · Cited by 79
Delayed Repolarization Underlies Ventricular Arrhythmias in Rats With Heart Failure and Preserved Ejection Fraction
Cho, J. H., Zhang, R., Kilfoil, P. J., Gallet, R., de Couto, G., Bresee, C. J., Goldhaber, J. I., Marbán, E., & Cingolani, E. (2017) · Circulation · doi:10.1161/circulationaha.117.028202 · Cited by 77
Understanding Heart Failure
Mazurek, J. A., & Jessup, M. L. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.08.001 · Cited by 78
Left Ventricular Dysfunction in Deteriorating Patients With Chronic Obstructive Pulmonary Disease
Render, M. L., Weinstein, A. S., & Blaustein, A. (1995) · CHEST Journal · doi:10.1378/chest.107.1.162 · Cited by 77
Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction
Khaper, N., Kaur, K., Li, T., Farahmand, F., & Singal, P. K. (2003) · Springer eBooks · doi:10.1007/978-1-4419-9238-3_2 · Cited by 77
Changing mortality in dilated cardiomyopathy
Lenarda, A. D., Secoli, G., Perkan, A., Gregori, D., Lardieri, G., Pinamonti, B., Sinagra, G., Zecchin, M., Camerini, F., & Heart Muscle Disease Study Group (1994) · Heart · doi:10.1136/hrt.72.6_suppl.s46 · Cited by 77
Treatment of Congestive Heart Failure
Gomberg‐Maitland, M., Baran, D. A., & Fuster, V. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.342 · Cited by 77
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 76
The meaning of hypokalemia in heart failure
Bielecka-Dabrowa, A. M., Mikhailidis, D. P., Jones, L. G., Rysz, J., Aronow, W. S., & Banach, M. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.121 · Cited by 77
CCORT/CCS quality indicators for congestive heart failure care.
Lee, D. S., Tran, C., Flintoft, V. F., Grant, F., Liu, P. P., & Tu, J. V. (2003) · PubMed · Cited by 76
Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study
Nanas, J. N., Alexopoulos, G. P., ANASTASIOU‐NANA, M. I., Karidis, K., Tirologos, A., Zobolos, S., Pirgakis, V., Anthopoulos, L., Sideris, D. A., Stamatelopoulos, S. F., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01025-1 · Cited by 76
Beneficial Effects of Adaptive Servo Ventilation in Patients With Chronic Heart Failure
Koyama, T., Watanabe, H., Kobukai, Y., Makabe, S., Munehisa, Y., Iino, K., Kosaka, T., & Ito, H. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0082 · Cited by 75
BiDil: Assessing a Race-Based Pharmaceutical
Brody, H., & Hunt, L. M. (2006) · The Annals of Family Medicine · doi:10.1370/afm.582 · Cited by 77
Peripartum cardiomyopathy: A longitudinal echocardiographic study
Witlin, A. G., Mabie, W. C., & Sibai, B. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70028-0 · Cited by 75
Diuretics for heart failure
Faris, R. F., Flather, M. D., Purcell, H., Poole-Wilson, P. A., & Coats, A. J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003838.pub2 · Cited by 81
Retracted
Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Organic Nitrates in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibition
Elkayam, U., Johnson, J. V., Shotan, A., Bokhari, S. R. A., Solodky, A., Canetti, M., Wani, O. R., & Karaalp, I. S. (1999) · Circulation · doi:10.1161/01.cir.99.20.2652 · Cited by 74
Polymorphisms of the renin-angiotensin system genes in progressive renal diseases
Yoshida, H., Kon, V., & Ichikawa, I. (1996) · Kidney International · doi:10.1038/ki.1996.371 · Cited by 74
Impact of a Guideline-Based Disease Management Team on Outcomes of Hospitalized Patients With Congestive Heart Failure
Costantini, O., Huck, K., Carlson, M. D., Boyd, K. K., Buchter, C. M., Raiz, P., & Cooper, G. S. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.177 · Cited by 74
Differentiating systolic from diastolic heart failure: Pathophysiologic and therapeutic considerations
Goldsmith, S. R., & DICK, C. D. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90361-r · Cited by 74
Underutilisation of ACE inhibitors in patients with congestive heart failure.
Bungard, T. J., McAlister, F. A., Johnson, J. A., & Tsuyuki, R. T. (2001) · Drugs · doi:10.2165/00003495-200161140-00002 · Cited by 73
A review of heart failure management in the elderly population
Cheng, J. W. M., & Nayar, M. (2009) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2009.10.001 · Cited by 73
Do cytokines enable risk stratification to be improved in NYHA functional class III patients?. Comparison with other potential predictors of prognosis
Kell, R. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2780 · Cited by 74
Cost-effectiveness analysis in heart disease, part III: Ischemia, congestive heart failure, and arrhythmias
Kupersmith, J., Holmes-Rovner, M. M., Hogan, A. J., Rovner, D. R., & Gardiner, J. C. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80017-9 · Cited by 73
Suppressing Sympathetic Activation in Congestive Heart Failure
Manolis, A. J., Olympios, C. D., Sifaki, M., Handanis, S. M., Bresnahan, M. R., Gavras, I., & Gavras, H. P. (1995) · Hypertension · doi:10.1161/01.hyp.26.5.719 · Cited by 73
Inositol‐1,4,5‐trisphosphate induced Ca2+ release and excitation–contraction coupling in atrial myocytes from normal and failing hearts
Hohendanner, F., Walther, S., Maxwell, J. T., Kettlewell, S., Awad, S. M. M., Smith, G. L., Lonchyna, V. A., & Blatter, L. A. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.283226 · Cited by 72
Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat
Sharma, V. S., Dhillon, P., Wambolt, R. B., Parsons, H., Brownsey, R. W., Allard, M. F., & McNeill, J. H. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00949.2007 · Cited by 72
Efficacy and dosage of enalapril in congenital and acquired heart disease.
Leversha, A., Wilson, N., Clarkson, P. M., Calder, A. L., Ramage, M. C., & Neutze, J. M. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.70.1.35 · Cited by 71
The Sympathetic Nervous System and the Renin–Angiotensin–Aldosterone System in Cardiovascular Disease
Cody, R. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00832-1 · Cited by 71
The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.
Liu, P. J., Arnold, M., Belenkie, I., Howlett, J. G., Huckell, V. F., Ignazewski, A., LeBlanc, M. H., McKelvie, R. S., Niznick, J., Parker, J. D., et al. (2001) · PubMed · Cited by 71
15 years of heart-failure trials: what have we learned?
Massie, B. M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90016-2 · Cited by 71
Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure
Yusuf, S., Garg, R., Held, P. H., & Gorlin, R. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91255-3 · Cited by 71
Clinical and left ventricular function outcomes up to five years after dynamic cardiomyoplasty
Moreira, L. F. P., Stolf, N. A. G., Bocchi, E. A., Bacal, F., Pêgo‐Fernandes, P. M., Absensur, H., Meneghetti, J. C., & Jatene, A. D. (1995) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70397-7 · Cited by 71
Atrial Natriuretic Peptide Levels in the Prediction of Congestive Heart Failure Risk in Frail Elderly
Davis, K. M. (1992) · JAMA · doi:10.1001/jama.1992.03480190067033 · Cited by 71
Target Heart Failure Populations for Newer Therapies
Stevenson, L. W., Couper, G., Natterson-Horowitz, B., Fonarow, G. C., Hamilton, M. A., Woo, M. A., & Creaser, J. W. (1995) · Circulation · doi:10.1161/01.cir.92.9.174 · Cited by 71
Mechanical Cardiac Support 2000: Current Applications and Future Trial Design
Stevenson, L. W., Kormos, R. L., Barr, M. L., Costanzo, M. R., Desvigne-Nickens, P. M., Feldman, A. M., Frazier, O. H., Friedman, L., Hill, J. D., Konstam, M. A., et al. (2001) · Circulation · doi:10.1161/01.cir.103.2.337 · Cited by 70
Phosphodiesterase inhibition in heart failure
Movsesian, M. A., Stehlik, J., Vandeput, F., & Bristow, M. R. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9130-x · Cited by 70
The role of neurohormonal activation in chronic heart failure and postmyocardial infarction
Sigurðsson, A. F., & Swedberg, K. B. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90558-x · Cited by 70
Calcium channel blockers in heart failure
Elkayam, U. (1998) · Cardiology · doi:10.1159/000047278 · Cited by 69
Accuracy of the automated assessment of left ventricular function with gated perfusion SPECT in the presence of perfusion defects and left ventricular dysfunction: Correlation with equilibrium radionuclide ventriculography and echocardiography
Chua, T., YIN, L. C., Thiang, T. H., Choo, T. B., Ping, D. Z., & Leng, L. Y. (2000) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2000.105279 · Cited by 69

Authors: Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., Bhat, G., Goldman, S., Fletcher, R. D., Doherty, J., Hughes, C. V., Carson, P., Cintron, G., Shabetai, R., & Haakenson, C.
Affiliations: University of Minnesota (US)
ORCID: Cohn, Jay N.
Johnson, Gary
Bhat, Geetha
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 303-310
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250502
OpenAlex: W2046383587
Cited by: 2,833
References: 19
Citations by year: 2026: 14 · 2025: 15 · 2024: 26 · 2023: 21 · 2022: 31 · 2021: 27 · 2020: 46 · 2019: 39 · 2018: 51 · 2017: 56 · 2016: 69 · 2015: 59 · 2014: 54 · 2013: 61 · 2012: 56
FWCI: 124.25
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, hydralazine, isosorbide dinitrate, chronic congestive heart failure, vasodilator therapy, mortality, sudden death, exercise oxygen consumption, left ventricular ejection fraction, ACE inhibitors, combination therapy, digoxin, diuretics, NYHA functional class
MeSH terms: Adolescent, Adult, Aged, Chronic Disease, Death, Sudden, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Enalapril, Physical Exertion, Heart Failure, Hospitalization, Humans, Hydralazine, Isosorbide Dinitrate, Male, Middle Aged, Norepinephrine, Oxygen Consumption, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks